Clinical trials with catechol-O-methyltransferase (COMT) inhibitors, entacapone and tolcapone

被引：1
|
作者：
Myllyla, Vilho [1 ]
机构：
[1] Univ Oulu, Oulu, Finland
来源：
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2008年 / 34卷 / 01期
关键词：
D O I：
10.1016/j.ejps.2008.02.030
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] Catechol-O-methyltransferase: variation in enzyme activity and inhibition by entacapone and tolcapone
    C. De Santi
    P. C. Giulianotti
    A. Pietrabissa
    F. Mosca
    G. M. Pacifici
    [J]. European Journal of Clinical Pharmacology, 1998, 54 : 215 - 219
  • [2] Catechol-O-methyltransferase:: variation in enzyme activity and inhibition by entacapone and tolcapone
    De Santi, C
    Giulianotti, PC
    Pietrabissa, A
    Mosca, F
    Pacifici, GM
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) : 215 - 219
  • [3] Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells
    Gruenig, David
    Felser, Andrea
    Duthaler, Urs
    Bouitbir, Jamal
    Kraehenbuehl, Stephan
    [J]. TOXICOLOGICAL SCIENCES, 2018, 164 (02) : 477 - 488
  • [4] TOLCAPONE (TO) INHIBITS BOTH PERIPHERAL AND CENTRAL CATECHOL-O-METHYLTRANSFERASE (COMT)
    DAPRADA, M
    ZURCHER, G
    NAPOLITANO, A
    [J]. NEUROLOGY, 1995, 45 (04) : A252 - A253
  • [5] The catechol-O-methyltransferase inhibitors tolcapone and entacapone uncouple and inhibit the mitochondrial respiratory chain in HepaRG cells
    Grunig, David
    Felser, Andrea
    Bouitbir, Jamal
    Krahenbuhl, Stephan
    [J]. TOXICOLOGY IN VITRO, 2017, 42 : 337 - 347
  • [6] The catechol-O-methyltransferase inhibitors tolcapone and entacapone uncouple and inhibit the mitochondrial respiratory chain in HepaRG cells
    Grunig, David
    Felser, Andrea
    Bouitbir, Jamal
    Krahenbuhl, Stephan
    [J]. CLINICAL TOXICOLOGY, 2017, 55 (05) : 437 - 438
  • [7] Catechol-O-methyltransferase (COMT) inhibitors in Parkinson's disease
    Waters, C
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (06) : 692 - 698
  • [8] Pharmacokinetics of levodopa and effect of catechol-O-methyltransferase inhibitors (COMT)
    de la Parte, JFH
    Hernández, MM
    [J]. NEUROLOGIA, 2002, 17 : 57 - 61
  • [9] Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT)
    Harrison, Scott T.
    Poslusney, Michael S.
    Mulhearn, James J.
    Zhao, Zhijian
    Kett, Nathan R.
    Schubert, Jeffrey W.
    Melamed, Jeffrey Y.
    Allison, Timothy J.
    Patel, Sangita B.
    Sanders, John M.
    Sharma, Sujata
    Smith, Robert F.
    Hall, Dawn L.
    Robinson, Ronald G.
    Sachs, Nancy A.
    Hutson, Pete H.
    Wolkenberg, Scott E.
    Barrow, James C.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (03): : 318 - 323
  • [10] CLINICAL POTENTIAL OF CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS AS ADJUVANTS IN PARKINSONS-DISEASE
    MANNISTO, PT
    [J]. CNS DRUGS, 1994, 1 (03) : 172 - 179
12345